Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat

• Päätekijät: Bahar Baniahmad (Tekijä), Leila Safaeian (Tekijä), Golnaz Vaseghi (Tekijä), Mohammad Rabbani (Tekijä), Behnoosh Mohammadi (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background and purpose: Doxorubicin (DOX) is an effective agent for the treatment of many neoplastic diseases. Cardiotoxicity is the major side effect of this drug and limits its use. Vanillic acid (VA) is a pharmaceutical compound from the phenolic acids family. The present study is an attempt to i...